Ontology highlight
ABSTRACT: Background
To evaluate the potential clinical value of cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) in the diagnosis and monitors the central nervous system (CNS) lymphomas.Methods
This was a prospective study of 17 consecutive patients with B-cell lymphoma: 10 patients with CNS lymphomas and 7 patients with B-cell lymphomas at high clinical risk of CNS relapse. Genomic profiles were performed on the CSF and plasma samples of patients by next-generation sequencing.Results
In patients with CNS lymphomas, ctDNA was detected in 70.0% of CSF and 60.0% of plasma. The detection rate and gene mutation abundance of CSF were higher than plasma (p = 0.016). CSF had a unique genetic profile. Furthermore, we newly found that gene mutations consistent with plas
SUBMITTER: Fu H
PROVIDER: S-EPMC11851744 | biostudies-literature | 2025
REPOSITORIES: biostudies-literature